| Citation Matrix | Glossary HistCite Guide |
| Gene expression profiling predicts clinical outcome of breast cancer van't Veer LJ, Dai HY, van de Vijver MJ, He YDD, Hart AAM, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH NATURE 415 (6871): 530-536 JAN 31 2002 and the papers citing them. |
Nodes: 336,
Authors: 1598,
Sources: 171,
Outer References: 11018
Collection span: 2002 - 2003
LCSb: 105 (31.25%) nodes before 2003
(1 years)
LCSe: 231 (68.75%) nodes after 2002
(1 years)
View: Bibliometric. Sorted by year, source, volume, issue, page.
Page 1: 1 2
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 39 | 1 2002 ACADEMIC RADIOLOGY 9(9):999-1003
Li KCP Biomedical imaging in the postgenomic era: Opportunities and challenges | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 2 | 2 | 41 | 2 2002 AMERICAN JOURNAL OF PATHOLOGY 161(4):1223-1233
Ginestier C; Charafe-Jauffret E; Bertucci F; Eisinger F; Geneix J; Bechlian D; Conte N; Adelaide J; Toiron Y; Nguyen C; Viens P; Mozziconacci MJ; Houlgatte R; Birnbaum D; Jacquemier J Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers | 2 | 1.00 | 8 | 4.00 | 0 | 2 |
| 3 | 1 | 33 | 3 2002 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 27(2):125-132
Kaminski N; Friedman N Practical approaches to analyzing results of microarray experiments | 1 | 0.50 | 9 | 4.50 | 0 | 1 |
| 4 | 1 | 27 | 4 2002 ANNALS OF ONCOLOGY 13():207-210
Aapro MS Progress in the treatment of breast cancer in the elderly | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 5 | 2 | 26 | 5 2002 ANNALS OF SURGICAL ONCOLOGY 9(10):941-943
Roukos DH; Agnanti NJ; Paraskevaidis E; Kappas AM Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 6 | 2 | 57 | 6 2002 ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 37 37():225-236
McLaughlin F; LaThangue N Tumor classification for tailored cancer therapy | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 7 | 1 | 21 | 7 2002 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 296(2):497-506
Ichikawa Y; Ishikawa T; Takahashi S; Hamaguchi Y; Morita T; Nishizuka I; Yamaguchi S; Endo I; Ike H; Togo S; Oki S; Shimada H; Kadota K; Nakamura S; Goto H; Nitanda H; Satomi S; Sakai T; Narita I; Gejyo F; Tomaru Y; Shimizu K; Hayashizaki Y; Okazaki Y Identification of genes regulating colorectal carcinogenesis by using the algorithm for diagnosing malignant state method | 0 | 0.00 | 2 | 1.00 | 0 | 0 |
| 8 | 1 | 30 | 8 2002 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 299(5):839-846
Atalay A; Crook T; Ozturk M; Yulug IG Identification of genes induced by BRCA1 in breast cancer cells | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 9 | 1 | 33 | 9 2002 BMC GENOMICS 3():art. no.-31
Zhao HJ; Hastie T; Whitfield ML; Borresen-Dale AL; Jeffrey SS Optimization and evaluation of T7 based RNA linear amplification protocols for cDNA microarray analysis | 0 | 0.00 | 9 | 4.50 | 0 | 0 |
| 10 | 1 | 57 | 10 2002 BREAST 11(6):501-508
Lifrange E; Dondelinger RF; Foidart JM; Bradfer J; Quatresooz P; Colin C Percutaneous stereotactic en bloc excision of nonpalpable breast carcinoma: a step in the direction of supraconservative surgery | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 11 | 1 | 6 | 11 2002 BREAST CANCER RESEARCH 4(4):141-144
Liu ET; Sotiriou C Defining the galaxy of gene expression in breast cancer | 2 | 1.00 | 3 | 1.50 | 0 | 2 |
| 12 | 1 | 11 | 12 2002 BREAST CANCER RESEARCH 5(1):23-26
Gruvberger SK; Ringner M; Eden P; Borg A; Ferno M; Peterson C; Meltzer PS Expression profiling to predict outcome in breast cancer: the influence of sample selection | 1 | 0.50 | 2 | 1.00 | 1 | 0 |
| 13 | 2 | 3 | 13 2002 BREAST CANCER RESEARCH 5(1):57-58
van 't Veer LJ; Dai HY; van de Vijver MJ; He YDD; Hart AAM; Bernards R; Friend SH Expression profiling predicts outcome in breast cancer | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 14 | 1 | 10 | 14 2002 BULLETIN DU CANCER 89(6):571-574
Bertucci F; Nasser V; Houlgatte W; Birnbaum D Gene expression profiling using cDNA arrays and prognosis of breast cancer | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 15 | 1 | 14 | 15 2002 CA-A CANCER JOURNAL FOR CLINICIANS 52(5):253-255
Ganz PA Breast cancer 2002: Where do we stand? | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 16 | 1 | 37 | 16 2002 CANCER 95(12):2465-2472
Blackman SB; Lash TL; Fink AK; Ganz PA; Silliman RA Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients | 0 | 0.00 | 2 | 1.00 | 0 | 0 |
| 17 | 1 | 4 | 17 2002 CANCER BIOLOGY & THERAPY 1(4):436-437
El-Deiry WS Phenomenology and scientific progress | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 18 | 1 | 9 | 18 2002 CANCER CELL 1(1):15-17
Ince TA; Weinberg RA Functional genomics and the breast cancer problem | 4 | 2.00 | 5 | 2.50 | 1 | 3 |
| 19 | 1 | 23 | 19 2002 CANCER CELL 1(2):203-209
Singh D; Febbo PG; Ross K; Jackson DG; Manola J; Ladd C; Tamayo P; Renshaw AA; D'Amico AV; Richie JP; Lander ES; Loda M; Kantoff PW; Golub TR; Sellers WR Gene expression correlates of clinical prostate cancer behavior | 17 | 8.50 | 61 | 30.50 | 7 | 10 |
| 20 | 1 | 46 | 20 2002 CANCER CELL 1(4):299-305
Baylin S; Bestor TH Altered methylation patterns in cancer cell genomes: Cause or consequence? | 1 | 0.50 | 28 | 14.00 | 0 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 21 | 2 | 39 | 21 2002 CANCER CELL 1(4):319-322
Baselga J; Norton L Focus on breast cancer | 0 | 0.00 | 4 | 2.00 | 0 | 0 |
| 22 | 3 | 36 | 22 2002 CANCER CELL 2(5):353-361
Miller LD; Long PM; Wong L; Mukherjee S; McShane LM; Liu ET Optimal gene expression analysis by microarrays | 1 | 0.50 | 8 | 4.00 | 0 | 1 |
| 23 | 1 | 11 | 23 2002 CANCER JOURNAL 8(6):461-468
Buchholz TA; Stivers DN; Stec J; Ayers M; Clark E; Bolt A; Sahin AA; Symmans WF; Hess KR; Kuerer HM; Valero V; Hortobagyi GN; Pusztai L Global gene expression changes during neoadjuvant chemotherapy for human breast cancer | 0 | 0.00 | 2 | 1.00 | 0 | 0 |
| 24 | 1 | 31 | 24 2002 CANCER RESEARCH 62(21):6211-6217
Redon R; Hussenet T; Bour G; Caulee K; Jost B; Muller D; Abecassis J; du Manoir S Amplicon mapping and transcriptional analysis pinpoint cyclin L as a candidate oncogene in head and neck cancer | 0 | 0.00 | 4 | 2.00 | 0 | 0 |
| 25 | 1 | 102 | 25 2002 CHEMISTRY AND PHYSICS OF LIPIDS 121(1-2):241-256
Pollock JD Gene expression profiling: methodological challenges, results, and prospects for addiction research | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 26 | 1 | 50 | 26 2002 CLINICAL CANCER RESEARCH 8(12):3910-3921
Yoo GH; Piechocki MP; Ensley JF; Nguyen T; Oliver J; Meng H; Kewson D; Shibuya TY; Lonardo F; Tainsky MA Docetaxel induced gene expression patterns in head and neck squamous cell carcinoma using cDNA microarray and PowerBlot | 0 | 0.00 | 3 | 1.50 | 0 | 0 |
| 27 | 1 | 37 | 27 2002 CLINICAL CARDIOLOGY 25(11):I9-I15
Topol EJ Economics and quality of care for patients with acute coronary syndromes: The impending crisis | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 28 | 1 | 77 | 28 2002 CLINICAL CHEMISTRY 48(8):1178-1185
Bernard PS; Wittwer CT Real-time PCR technology for cancer diagnostics | 0 | 0.00 | 10 | 5.00 | 0 | 0 |
| 29 | 1 | 132 | 29 2002 CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION 12(2):137-150
Lev DC; Price JE Therapeutic intervention with breast cancer metastasis | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 30 | 1 | 43 | 30 2002 CURRENT OPINION IN HEMATOLOGY 9(4):339-344
Armstrong SA; Hsieh JJD; Korsmeyer SJ Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemias | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 31 | 1 | 39 | 31 2002 CURRENT OPINION IN MICROBIOLOGY 5(3):334-337
Shoemaker DD; Linsley PS Recent developments in DNA microarrays | 0 | 0.00 | 11 | 5.50 | 0 | 0 |
| 32 | 1 | 19 | 32 2002 CURRENT OPINION IN ONCOLOGY 14(6):589-593
Domchek SM; Weber BL Recent advances in breast cancer biology | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 33 | 2 | 36 | 33 2002 CURRENT OPINION IN PHARMACOLOGY 2(5):551-554
Crowther DJ Applications of microarrays in the pharmaceutical industry | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 34 | 2 | 183 | 34 2002 CURRENT PROBLEMS IN CANCER 26(5):282-309
Johnstone PAS; Takimoto CHM; Goulet R NF-kappa B and breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 35 | 1 | 22 | 35 2002 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 127(17):901-906
Neubauer A; Wolf M; Engenhart-Cabillic R; Rothmund M Function and task of an interdisciplinary tumour center: Need of a Cancer Center for multimodal treatment concepts | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 36 | 1 | 70 | 36 2002 DEVELOPMENT 129(24):5767-5778
Hoffman MP; Kidder BL; Steinberg ZL; Lakhani S; Ho S; Kleinman HK; Larsen M Gene expression profiles of mouse submandibular gland development: FGFR1 regulates branching morphogenesis in vitro through BMP-and FGF-dependent mechanisms | 0 | 0.00 | 5 | 2.50 | 0 | 0 |
| 37 | 1 | 39 | 37 2002 ELECTROPHORESIS 23(11):1667-1676
Ojala P; Sundstrom J; Gronroos JM; Virtanen E; Talvinen K; Nevalainen TJ mRNA differential display of gene expression in colonic carcinoma | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 38 | 1 | 107 | 38 2002 ENDOCRINE-RELATED CANCER 9(4):207-220
Desai KV; Kavanaugh CJ; Calvo A; Green JE Chipping away at breast cancer: insights from microarray studies of human and mouse mammary cancer | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 39 | 1 | 87 | 39 2002 ENDOCRINOLOGY 143(6):1983-1989
Afshari CA Perspective: Microarray technology, seeing more than spots | 1 | 0.50 | 7 | 3.50 | 0 | 1 |
| 40 | 1 | 96 | 40 2002 ENDOCRINOLOGY 143(6):2029-2040
Simard J; Dumont M; Soucy P; Labrie F Perspective: Prostate cancer susceptibility genes | 1 | 0.50 | 6 | 3.00 | 0 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 41 | 1 | 38 | 41 2002 EUROPEAN JOURNAL OF CANCER 38(13):1730-1738
Friedrichs K; Holzel F; Janicke F Combination of taxanes and anthracyclines in first-line chemotherapy of metastatic breast cancer: an interim report | 0 | 0.00 | 2 | 1.00 | 0 | 0 |
| 42 | 2 | 54 | 42 2002 FRONTIERS IN BIOSCIENCE 7():C74-C82
Hunter SB; Moreno CS Expression microarray analysis of brain tumors: What have we learned so far | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 43 | 1 | 36 | 43 2002 GENES & DEVELOPMENT 16(6):681-686
Shvarts A; Brummelkamp TR; Scheeren F; Koh E; Daley GQ; Spits H; Bernards R A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling | 1 | 0.50 | 15 | 7.50 | 0 | 1 |
| 44 | 1 | 80 | 44 2002 GYNAKOLOGE 35(6):527-536
Beckmann MW; Fasching PA; Gall C; Bani M; Brumm C; Kramer S Genetic risk factors in breast cancer | 1 | 0.50 | 1 | 0.50 | 1 | 0 |
| 45 | 2 | 36 | 45 2002 GYNAKOLOGE 35(9):872-880
Beckmann MW Molecular obstetrics and gynecology | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 46 | 1 | 37 | 46 2002 HEART SURGERY FORUM 5(3):258-264
Wyse RKH; Taylor KM Using the STS and multinational cardiac surgical databases to establish risk-adjusted benchmarks for clinical outcomes | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 47 | 1 | 31 | 47 2002 HUMAN GENETICS 111(4-5):411-420
Jenssen TK; Kuo WP; Stokke T; Hovig E Associations between gene expressions in breast cancer and patient survival | 1 | 0.50 | 1 | 0.50 | 0 | 1 |
| 48 | 1 | 65 | 48 2002 IN VIVO 16(6):423-429
Onn A; Fidler IJ Metastatic potential of human neoplasms | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 49 | 1 | 43 | 49 2002 INTERNATIONAL JOURNAL OF CANCER 102(1):86-90
Karamouzis MV; Likaki-Karatza E; Ravazoula P; Badra FA; Koukouras D; Tzorakoleftherakis E; Papavassiliou AG; Kalofonos HP Non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 50 | 1 | 26 | 50 2002 JAPANESE JOURNAL OF CANCER RESEARCH 93(11):1207-1212
Ando T; Suguro M; Hanai T; Kobayashi T; Honda H; Seto M Fuzzy neural network applied to gene expression profiling for predicting the prognosis of diffuse large B-cell lymphoma | 0 | 0.00 | 3 | 1.50 | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 51 | 1 | 33 | 51 2002 JOURNAL OF BIOMEDICAL INFORMATICS 35(3):160-170
Bushel PR; Hamadeh HK; Bennett L; Green J; Ableson A; Misener S; Afshari CA; Paules RS Computational selection of distinct class-and subclass-specific gene expression signatures | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 52 | 1 | 39 | 52 2002 JOURNAL OF CLINICAL INVESTIGATION 110(5):633-641
Signoretti S; Di Marcotullio L; Richardson A; Ramaswamy S; Isaac B; Rue M; Monti F; Loda M; Pagano M Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer | 1 | 0.50 | 14 | 7.00 | 0 | 1 |
| 53 | 1 | 22 | 53 2002 JOURNAL OF CLINICAL ONCOLOGY 20(18):3758-3760
Schellens JHM; Ratain MJ Endostatin: Are the 2 years up yet? | 0 | 0.00 | 5 | 2.50 | 0 | 0 |
| 54 | 1 | 48 | 54 2002 JOURNAL OF MOLECULAR ENDOCRINOLOGY 29(2):175-192
Inoue A; Yoshida N; Omoto Y; Oguchi S; Yamori T; Kiyama R; Hayashi S Development of cDNA microarray for expression profiling of estrogen-responsive genes | 2 | 1.00 | 6 | 3.00 | 0 | 2 |
| 55 | 1 | 38 | 55 2002 JOURNAL OF NUTRITION 132(12):3632-3637
Endo Y; Fu ZW; Abe K; Arai S; Kato H Dietary protein quantity and quality affect rat hepatic gene expression | 0 | 0.00 | 3 | 1.50 | 0 | 0 |
| 56 | 1 | 112 | 56 2002 JOURNAL OF PHYSICS D-APPLIED PHYSICS 35(9):R61-R76
Cubeddu R; Comelli D; D'Andrea C; Taroni P; Valentini G Time-resolved fluorescence imaging in biology and medicine | 0 | 0.00 | 6 | 3.00 | 0 | 0 |
| 57 | 1 | 22 | 57 2002 JOURNAL OF THE NATIONAL CANCER INSTITUTE 94(13):960-961
Hedenfalk IA Gene expression profiling of hereditary and sporadic ovarian cancers reveals unique BRCA1 and BRCA2 signatures | 1 | 0.50 | 1 | 0.50 | 1 | 0 |
| 58 | 1 | 48 | 58 2002 LABORATORY INVESTIGATION 82(11):1525-1533
Korsching E; Packeisen J; Agelopoulos K; Eisenacher M; Voss R; Isola J; van Diest PJ; Brandt B; Boecker W; Buerger H Cytogenetic alterations and cytokeratin expression patterns in breast cancer: Integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis | 3 | 1.50 | 7 | 3.50 | 0 | 3 |
| 59 | 1 | 5 | 59 2002 LANCET 360(9327):173-174
Bertucci F; Eisinger F; Houlgatte R; Viens P; Birnbaum D Gene-expression profiling and identification of patients at high risk of breast cancer | 2 | 1.00 | 3 | 1.50 | 1 | 1 |
| 60 | 1 | 81 | 60 2002 LANCET 360(9338):1007-1014
Kennedy RD; Quinn JE; Johnston PG; Harkin DP BRCA1: mechanisms of inactivation and implications for management of patients | 1 | 0.50 | 3 | 1.50 | 0 | 1 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 61 | 1 | 48 | 61 2002 LANCET ONCOLOGY 3(6):349-356
Fey MF Impact of the Human Genome Project on the clinical management of sporadic cancers | 0 | 0.00 | 2 | 1.00 | 0 | 0 |
| 62 | 1 | 23 | 62 2002 MICROARRAYS, IMMUNE RESPONSES AND VACCINES 975():217-231
Bertucci F; Houlgatte R; Granjeaud S; Nasser V; Loriod B; Beaudoing E; Hingamp P; Jacquemier J; Viens P; Birnbaum D; Nguyen C Prognosis of breast cancer and gene expression profiling using DNA arrays | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 63 | 1 | 253 | 63 2002 MICROSCOPY RESEARCH AND TECHNIQUE 59(1):68-83
Daniel DC Highlight: BRCA1 and BRCA2 proteins in breast cancer | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 64 | 2 | 29 | 64 2002 MOLECULAR CANCER THERAPEUTICS 1(10):769-776
Huang KC; Rao PH; Lau CC; Heard E; Ng SK; Brown C; Mok SC; Berkowitz RS; Ng SW Relationship of XIST expression and responses of ovarian cancer to chemotherapy | 1 | 0.50 | 2 | 1.00 | 0 | 1 |
| 65 | 1 | 10 | 65 2002 NATURE 415(6871):484-485
Caldas C; Aparicio SAJ Cancer - The molecular outlook | 7 | 3.50 | 8 | 4.00 | 3 | 4 |
| 66 | 0 | 26 | 66 2002 NATURE 415(6871):530-536
vantVeer LJ; Dai HY; van de Vijver MJ; He YDD; Hart AAM; Mao M; Peterse HL; van der Kooy K; Marton MJ; Witteveen AT; Schreiber GJ; Kerkhoven RM; Roberts C; Linsley PS; Bernards R; Friend SH Gene expression profiling predicts clinical outcome of breast cancer | 335 | 167.50 | 335 | 167.50 | 104 | 231 |
| 67 | 1 | 16 | 67 2002 NATURE 416(6880):470-474
Abbott A On the offensive | 0 | 0.00 | 8 | 4.00 | 0 | 0 |
| 68 | 1 | 4 | 68 2002 NATURE 418(6893):11-13
Ball P Data visualization: Picture this | 0 | 0.00 | 2 | 1.00 | 0 | 0 |
| 69 | 1 | 4 | 69 2002 NATURE 418(6900):823-823
Bernards R; Weinberg RA Metastasis genes: A progression puzzle | 17 | 8.50 | 45 | 22.50 | 2 | 15 |
| 70 | 1 | 48 | 70 2002 NATURE CELL BIOLOGY 4(5):358-366
Hsu JY; Reimann JDR; Sorensen CS; Lukas J; Jackson PK E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APC(Cdh1) | 1 | 0.50 | 13 | 6.50 | 1 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 71 | 1 | 65 | 71 2002 NATURE GENETICS 32():474-479
Petricoin EF; Hackett JL; Lesko LJ; Puri RK; Gutman SI; Chumakov K; Woodcock J; Feigal DW; Zoon KC; Sistare FD Medical applications of microarray technologies: a regulatory science perspective | 0 | 0.00 | 16 | 8.00 | 0 | 0 |
| 72 | 2 | 73 | 72 2002 NATURE GENETICS 32():481-489
Holloway AJ; van Laar RK; Tothill RW; Bowtell DDL Options available - from start to finish - for obtaining data from DNA microarrays | 4 | 2.00 | 23 | 11.50 | 0 | 4 |
| 73 | 3 | 98 | 73 2002 NATURE GENETICS 32():502-508
Slonim DK From patterns to pathways: gene expression data analysis comes of age | 4 | 2.00 | 36 | 18.00 | 2 | 2 |
| 74 | 4 | 50 | 74 2002 NATURE GENETICS 32():533-540
Chung CH; Bernard PS; Perou CM Molecular portraits and the family tree of cancer | 2 | 1.00 | 20 | 10.00 | 1 | 1 |
| 75 | 2 | 2 | 75 2002 NATURE REVIEWS CANCER 2(3):157-157
Greenwood E Tailor-made therapy | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 76 | 1 | 164 | 76 2002 NATURE REVIEWS CANCER 2(6):442-454
Thiery JP Epithelial-mesenchymal transitions in tumour progression | 2 | 1.00 | 54 | 27.00 | 0 | 2 |
| 77 | 1 | 113 | 77 2002 NATURE REVIEWS GENETICS 3(6):415-428
Jones PA; Baylin SB The fundamental role of epigenetic events in cancer | 6 | 3.00 | 171 | 85.50 | 0 | 6 |
| 78 | 1 | 29 | 78 2002 NATURE REVIEWS GENETICS 3(8):579-588
Yang YH; Speed T Design issues for cDNA microarray experiments | 7 | 3.50 | 44 | 22.00 | 3 | 4 |
| 79 | 1 | 79 | 79 2002 NEUROCHEMICAL RESEARCH 27(10):1005-1026
Sendera TJ; Dorris D; Ramakrishnan R; Nguyen A; Trakas D; Mazumder A Expression profiling with oligonucleotide arrays: Technologies and applications for neurobiology | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 80 | 1 | 5 | 80 2002 NEW ENGLAND JOURNAL OF MEDICINE 346(11):863-864
Bartelink H; Horiot JC; Poortmans P Radiotherapy for breast cancer - Reply | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 81 | 1 | 12 | 81 2002 NEW ENGLAND JOURNAL OF MEDICINE 346(25):1998-1999
Magrath I Molecular characteristics of diffuse large-B-cell lymphoma | 0 | 0.00 | 2 | 1.00 | 0 | 0 |
| 82 | 2 | 20 | 82 2002 NEW ENGLAND JOURNAL OF MEDICINE 347(25):1999-2009
van de Vijver MJ; He YD; van 't Veer LJ; Dai H; Hart AAM; Voskuil DW; Schreiber GJ; Peterse JL; Roberts C; Marton MJ; Parrish M; Atsma D; Witteveen A; Glas A; Delahaye L; van der Velde T; Bartelink H; Rodenhuis S; Rutgers ET; Friend SH; Bernards R A gene-expression signature as a predictor of survival in breast cancer. | 36 | 18.00 | 84 | 42.00 | 1 | 35 |
| 83 | 2 | 10 | 83 2002 NEW ENGLAND JOURNAL OF MEDICINE 347(25):2067-2068
Kallioniemi A Molecular signatures of breast cancer - Predicting the future. | 1 | 0.50 | 3 | 1.50 | 0 | 1 |
| 84 | 1 | 22 | 84 2002 NUCLEIC ACIDS RESEARCH 30(21):art. no.-e116
Sterrenburg E; Turk R; Boer JM; van Ommen GB; den Dunnen JT A common reference for cDNA microarray hybridizations | 0 | 0.00 | 7 | 3.50 | 0 | 0 |
| 85 | 2 | 149 | 85 2002 ONCOGENE 21(40):6209-6221
Hansen DV; Hsu JY; Kaiser BK; Jackson PK; Eldridge AG Control of the centriole and centrosome cycles by ubiquitination enzymes | 0 | 0.00 | 2 | 1.00 | 0 | 0 |
| 86 | 1 | 51 | 86 2002 ONCOGENE 21(43):6559-6566
Mikkers H; Allen J; Berns A Proviral activation of the tumor suppressor E2 alpha contributes to T cell lymphomagenesis in E mu Myc transgenic mice | 0 | 0.00 | 2 | 1.00 | 0 | 0 |
| 87 | 1 | 34 | 87 2002 ONCOGENE 21(46):7034-7041
Archey WB; McEachern KA; Robson M; Offit K; Vaziri SAJ; Casey G; Borg A; Arrick BA Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers | 1 | 0.50 | 4 | 2.00 | 0 | 1 |
| 88 | 1 | 43 | 88 2002 ONCOGENE 21(49):7593-7597
Turpin E; Bieche I; Bertheau P; Plassa LF; Lerebours F; de Roquancourt A; Olivi M; Espie M; Marty M; Lidereau R; Vidaud M; de The H Increased incidence of ERBB2 overexpression and TP53 mutation in inflammatory breast cancer | 0 | 0.00 | 2 | 1.00 | 0 | 0 |
| 89 | 1 | 77 | 89 2002 ONCOGENE 21(58):8994-9007
Moynahan ME The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans | 0 | 0.00 | 5 | 2.50 | 0 | 0 |
| 90 | 1 | 31 | 90 2002 ONCOLOGY-NEW YORK 16(7):892-894
Ragaz J Neoadjuvant chemotherapy for operable breast cancer - The Green/Hortobagyi Article Reviewed | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 91 | 1 | 37 | 91 2002 PATHOLOGY 34(4):309-314
Armes JE; Venter DJ The pathology of inherited breast cancer | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 92 | 1 | 30 | 92 2002 PHARMACEUTICAL RESEARCH 19(12):1773-1778
Chin KV; Kong ANT Application of DNA Microarrays in pharmacogenomics and toxicogenomics | 0 | 0.00 | 2 | 1.00 | 0 | 0 |
| 93 | 1 | 14 | 93 2002 PHARMACOGENOMICS 3(2):157-160
Mansmann U; Winkelmann BR Classification and prediction in pharmacogenetics - context, construction and validation | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 94 | 1 | 55 | 94 2002 PHARMACOGENOMICS 3(3):403-415
Ringner M; Peterson C; Khan J Analyzing array data using supervised methods | 2 | 1.00 | 5 | 2.50 | 0 | 2 |
| 95 | 2 | 78 | 95 2002 PHARMACOGENOMICS 3(5):589-601
Chicurel ME; Dalma-Weiszhausz DD Microarrays in pharmacogenomics - advances and future promise | 0 | 0.00 | 6 | 3.00 | 0 | 0 |
| 96 | 1 | 61 | 96 2002 PHARMACOGENOMICS 3(5):651-667
Thallinger GG; Trajanoski S; Stocker G; Trajanoski Z Information management systems for pharmacogenomics | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 97 | 2 | 103 | 97 2002 PHARMACOGENOMICS 3(6):791-807
Scheel J; von Brevern MC; Horlein A; Fischer A; Schneider A; Bach A Yellow pages to the transcriptome | 0 | 0.00 | 2 | 1.00 | 0 | 0 |
| 98 | 2 | 7 | 98 2002 REVISTA DE INVESTIGACION CLINICA 54(4):292-294
Kato-Maeda M; Mohar A Genetic material: instructive manual for disease management; the breast cancer, as an example | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 99 | 1 | 18 | 99 2002 REVUE DES MALADIES RESPIRATOIRES 19(5):549-551
Zalcman G; Urban T New biological markers of lung cancer: toward targeted biotherapies? | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 100 | 1 | 4 | 100 2002 SCIENTIST 16(20):43-43
Kling J Hot papers - The DNA microarray: It's the proof in the protein pudding | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 101 | 1 | 105 | 101 2002 SEMINARS IN RADIATION ONCOLOGY 12(4):305-318
Dillon DA Molecular markers in the diagnosis and staging of breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 102 | 1 | 9 | 102 2002 STRAHLENTHERAPIE UND ONKOLOGIE 178(8):462-463
Belka C; Budach W Gene expression profiling predicts early metastasis in patients with nodal negative breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | 0 |
| 103 | 1 | 66 | 103 2002 TRENDS IN GENETICS 18(11):555-559
Kell DB Genotype-phenotype mapping: genes as computer programs | 0 | 0.00 | 3 | 1.50 | 0 | 0 |
| 104 | 1 | 55 | 104 2002 TRENDS IN MOLECULAR MEDICINE 8(6):288-293
Negm RS; Verma M; Srivastava S The promise of biomarkers in cancer screening and detection | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 105 | 1 | 63 | 105 2002 ZEITSCHRIFT FUR RHEUMATOLOGIE 61(4):396-404
Haupl T; Burmester GR; Stuhlmuller B New aspects in molecular biology diagnostics: array technology and expression profiling for characterization of rheumatic diseases | 0 | 0.00 | 1 | 0.50 | 0 | 0 |
| 106 | 1 | 30 | 106 2003 ACTA BIOCHIMICA ET BIOPHYSICA SINICA 35(9):829-833
Ding LH; Ye QN; Zhu JH; Yan JH; Zhong HJ; Wang ZH; Huang CF XBP-1 enhances the transcriptional activity of estrogen receptor alpha | 0 | 0.00 | 0 | 0.00 | 0 | |
| 107 | 2 | 25 | 107 2003 ACTA CHIRURGICA BELGICA 103(5):444-447
Mareel MM Physiopathology of liver metastasis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 108 | 1 | 31 | 108 2003 ADVANCES IN ANATOMIC PATHOLOGY 10(1):1-7
Oliveira AM; Fletcher JA CHIPing soft tissue tumors: Will the paradigms be changed? | 0 | 0.00 | 1 | 1.00 | 0 | |
| 109 | 5 | 17 | 109 2003 ADVANCES IN ANATOMIC PATHOLOGY 10(6):338-346
Master SR; Mies C Gene-expression profiles and breast-cancer prognosis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 110 | 5 | 134 | 110 2003 ADVANCES IN CANCER RESEARCH, VOL 89 89():35-67
Klein CA The systemic progression of human cancer: A focus on the individual disseminated cancer cell - The unit of selection | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 111 | 2 | 23 | 111 2003 AMERICAN JOURNAL OF PATHOLOGY 162(2):373-379
Maierhofer C; Gangnus R; Diebold J; Speicher MR Multicolor deconvolution Microscopy of thick biological specimens | 0 | 0.00 | 0 | 0.00 | 0 | |
| 112 | 1 | 29 | 112 2003 AMERICAN JOURNAL OF PATHOLOGY 163(2):543-552
Grzmil M; Thelen P; Hemmerlein B; Schweyer S; Voigt S; Mury D; Burfeind P Bax inhibitor-1 is overexpressed in prostate cancer and its specific down-regulation by RNA interference leads to cell death in human prostate carcinoma cells | 0 | 0.00 | 0 | 0.00 | 0 | |
| 113 | 2 | 25 | 113 2003 AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 29(3):S32-S36
Kaminski N Microarray analysis of idiopathic pulmonary fibrosis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 114 | 1 | 73 | 114 2003 AMERICAN JOURNAL OF SURGERY 186(4):351-358
Baker M; Gillanders WE; Mikhitarian K; Mitas M; Cole DJ The molecular detection of micrometastatic breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 115 | 1 | 39 | 115 2003 AMERICAN JOURNAL OF SURGICAL PATHOLOGY 27(2):199-205
Young AN; Salles PGD; Lim SD; Cohen C; Petros JA; Marshall FF; Neish AS; Amin MB Beta defensin-1, parvalbumin, and vimentin - A panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays | 0 | 0.00 | 1 | 1.00 | 0 | |
| 116 | 1 | 41 | 116 2003 ANALYTICA CHIMICA ACTA 490(1-2):365-378
Wu W; Roberts SLL; Armitage JR; Tooke P; Cordingley HC; Wildsmith SE Validation of consensus between proteomic and clinical chemistry datasets by applying a new randomisation F-test for generalised procrustes analysis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 117 | 2 | 48 | 117 2003 ANALYTICAL CHEMISTRY 75(17):4415-4422
Zhong WW; Yeung ES High-throughput analysis of total RNA expression profiles by capillary gel electrophoresis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 118 | 1 | 33 | 118 2003 ANNALS OF ONCOLOGY 14(5):663-665
Arriagada R; Gutierrez J Anthracyclines: is more, better and/or more dangerous? | 0 | 0.00 | 0 | 0.00 | 0 | |
| 119 | 1 | 54 | 119 2003 ANNALS OF ONCOLOGY 14(6):813-816
Garattini S New approaches to cancer therapy | 0 | 0.00 | 0 | 0.00 | 0 | |
| 120 | 1 | 65 | 120 2003 ANNALS OF SURGERY 237(4):474-482
Singletary SE Rating the risk factors for breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 121 | 1 | 148 | 121 2003 ANNUAL REVIEW OF PHYSIOLOGY 65():231-259
Gracey AY; Cossins AR Application of microarray technology in environmental and comparative physiology | 0 | 0.00 | 2 | 2.00 | 0 | |
| 122 | 1 | 36 | 122 2003 ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY 129(7):760-770
Sok JC; Kuriakose MA; Mahajan VB; Pearlman AN; DeLacure MD; Chen FA Tissue-specific gene expression of head and neck squamous cell carcinoma in vivo by complementary DNA microarray analysis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 123 | 1 | 44 | 123 2003 ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 127(11):1458-1464
Xu RL; Feiner H; Li P; Yee H; Inghirami G; Delgado Y; Perle MA Differential amplification and overexpression of HER-2/neu, p53, MIB1, and estrogen receptor/progesterone receptor among medullary carcinoma, atypical medullary carcinoma, and high-grade invasive ductal carcinoma of breast | 0 | 0.00 | 0 | 0.00 | 0 | |
| 124 | 1 | 28 | 124 2003 ARTHRITIS RESEARCH & THERAPY 5(2):47-50
Rogge L Gene profiling for defining targets for new therapeutics in autoimmune diseases | 0 | 0.00 | 0 | 0.00 | 0 | |
| 125 | 1 | 19 | 125 2003 ARTIFICIAL INTELLIGENCE REVIEW 20(1-2):39-51
Karzynski M; Mateos A; Herrero J; Dopazo J Using a genetic algorithm and a perceptron for feature selection and supervised class learning in DNA microarray data | 0 | 0.00 | 0 | 0.00 | 0 | |
| 126 | 2 | 88 | 126 2003 BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER 1603(2):99-111
Watters JW; McLeod HL Cancer pharmacogenomics: current and future applications | 0 | 0.00 | 2 | 2.00 | 0 | |
| 127 | 3 | 67 | 127 2003 BIOINFORMATICS 19(8):956-965
He YDD; Dai HY; Schadt EE; Cavet G; Edwards SW; Stepaniants SB; Duenwald S; Kleinhanz R; Jones AR; Shoemaker DD; Stoughton RB Microarray standard data set and figures of merit for comparing data processing methods and experiment designs | 0 | 0.00 | 0 | 0.00 | 0 | |
| 128 | 1 | 49 | 128 2003 BIOINFORMATICS 19(14):1787-1799
Sharan R; Maron-Katz A; Shamir R CLICK and EXPANDER: a system for clustering and visualizing gene expression data | 0 | 0.00 | 0 | 0.00 | 0 | |
| 129 | 1 | 11 | 129 2003 BIOINFORMATICS 19(14):1824-1831
Galinsky VL Automatic registration of microarray images. I. Rectangular grid | 0 | 0.00 | 0 | 0.00 | 0 | |
| 130 | 3 | 9 | 130 2003 BIOINFORMATICS 19(16):2065-2071
Smid M; Dorssers LCJ; Jenster G Venn Mapping: clustering of heterologous microarray data based on the number of co-occurring differentially expressed genes | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 131 | 1 | 22 | 131 2003 BIOINFORMATICS 19(16):2088-2096
Oba S; Sato M; Takemasa I; Monden M; Matsubara K; Ishii S A Bayesian missing value estimation method for gene expression profile data | 0 | 0.00 | 0 | 0.00 | 0 | |
| 132 | 2 | 31 | 132 2003 BIOTECHNIQUES ():30-+
Ringner M; Peterson C Microarray-based cancer diagnosis with artificial neural networks | 0 | 0.00 | 0 | 0.00 | 0 | |
| 133 | 1 | 34 | 133 2003 BIOTECHNIQUES ():36-44
Anderle P; Duval M; Draghici S; Kuklin A; Littlejohn TG; Medrano JE; Vilanova D; Roberts MA Gene expression databases and data mining | 0 | 0.00 | 2 | 2.00 | 0 | |
| 134 | 1 | 40 | 134 2003 BIOTECHNIQUES ():45-51
Dudoit S; Gendeman RC; Quackenbush J Open source software for the analysis of microarray data | 0 | 0.00 | 1 | 1.00 | 0 | |
| 135 | 1 | 60 | 135 2003 BIOTECHNIQUES ():64-+
O'Neill GM; Catchpoole DR; Golemis EA From correlation to causality: Microarrays, cancer, and cancer treatment | 0 | 0.00 | 0 | 0.00 | 0 | |
| 136 | 1 | 28 | 136 2003 BIOTECHNIQUES 34(1):124-130
Pavlickova P; Knappik A; Kambhampati D; Ortigao F; Hug H Microarray of recombinant antibodies using a streptavidin sensor surface self-assembled onto a gold layer | 0 | 0.00 | 3 | 3.00 | 0 | |
| 137 | 1 | 12 | 137 2003 BIOTECHNIQUES 35(4):828-835
Korkola JE; Estep ALH; Pejavar S; DeVries S; Jensen R; Waldman FM Optimizing stringency for expression microarrays | 0 | 0.00 | 0 | 0.00 | 0 | |
| 138 | 1 | 67 | 138 2003 BLOOD 101(12):4998-5006
Magrangeas F; Nasser V; Avet-Loiseau H; Loriod B; Decaux O; Granjeaud S; Bertucci F; Birnbaum D; Nguyen C; Harousseau JL; Bataille R; Houlgatte F; Minvielle S Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease | 0 | 0.00 | 0 | 0.00 | 0 | |
| 139 | 1 | 37 | 139 2003 BLOOD 102(5):1849-1856
Yagi T; Morimoto A; Eguchi M; Hibi S; Sako M; Ishii E; Mizutani S; Imashuku S; Ohki M; Ichikawa H Identification of a gene expression signature associated with pediatric AML prognosis | 0 | 0.00 | 1 | 1.00 | 0 | |
| 140 | 1 | 12 | 140 2003 BMC BIOINFORMATICS 4():art. no.-13
O'Neill MC; Song L Neural network analysis of lymphoma microarray data: prognosis and diagnosis near-perfect | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 141 | 1 | 31 | 141 2003 BMC CANCER 3():art. no.-3
DePrimo SE; Wong LM; Khatry DB; Nicholas SL; Manning WC; Smolich BD; O'Farrell AM; Cherrington JM Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identification | 0 | 0.00 | 0 | 0.00 | 0 | |
| 142 | 1 | 48 | 142 2003 BREAST CANCER RESEARCH 5(2):101-106
Vincent-Salomon A; Thiery JP Host microenvironment in breast cancer development - Epithelial-mesenchymal transition in breast cancer development | 0 | 0.00 | 2 | 2.00 | 0 | |
| 143 | 2 | 27 | 143 2003 BREAST CANCER RESEARCH 5(3):154-159
de Bono JS; Tolcher AW; Rowinsky EK The future of cytotoxic therapy: selective cytotoxicity based on biology is the key | 0 | 0.00 | 0 | 0.00 | 0 | |
| 144 | 3 | 9 | 144 2003 BREAST CANCER RESEARCH 5(6):303-304
Cardoso F Microarray technology and its effect on breast cancer (re)classification and prediction of outcome | 0 | 0.00 | 0 | 0.00 | 0 | |
| 145 | 5 | 73 | 145 2003 BREAST CANCER RESEARCH 5(6):320-328
Jeffrey SS; Pollack JR The diagnosis and management of pre-invasive breast disease - Promise of new technologies in understanding pre-invasive breast lesions | 0 | 0.00 | 2 | 2.00 | 0 | |
| 146 | 2 | 40 | 146 2003 BREAST CANCER RESEARCH AND TREATMENT 82(1):1-9
Sensi E; Tancredi M; Aretini P; Cipollini G; Naccarato AG; Viacava P; Bevilacqua G; Caligo MA P53 inactivation is a rare event in familial breast tumors negative for BRCA1 and BRCA2 mutations | 0 | 0.00 | 0 | 0.00 | 0 | |
| 147 | 1 | 14 | 147 2003 BRITISH JOURNAL OF CANCER 88(7):1091-1094
Weigelt B; Bosma AJ; Hart AAM; Rodenhuis S; van't Veer LJ Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients | 0 | 0.00 | 0 | 0.00 | 0 | |
| 148 | 1 | 32 | 148 2003 BRITISH JOURNAL OF CANCER 88(12):1831-1838
Schrama JG; Holtkamp MJ; Baars JW; Schornagel JH; Rodenhuis S Toxicity of the high-dose chemotherapy CTC regimen (cyclophosphamide, thiotepa, carboplatin): the Netherlands Cancer Institute experience | 0 | 0.00 | 0 | 0.00 | 0 | |
| 149 | 1 | 41 | 149 2003 BRITISH JOURNAL OF CANCER 89(2):314-319
Margalit O; Eisenbach L; Amariglio N; Kaminski N; Harmelin A; Pfeffer R; Shohat M; Rechavi G; Berger R Overexpression of a set of genes, including WISP-1, common to pulmonary metastases of both mouse D122 Lewis lung carcinoma and B16-F10.9 melanoma cell lines | 0 | 0.00 | 0 | 0.00 | 0 | |
| 150 | 1 | 23 | 150 2003 BRITISH JOURNAL OF CANCER 89(6):1031-1034
Goffin JR; Straume O; Chappuis PO; Brunet JS; Begin LR; Hamel N; Wong N; Akslen LA; Foulkes WD Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer | 0 | 0.00 | 1 | 1.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 151 | 2 | 26 | 151 2003 BRITISH JOURNAL OF CANCER 89(9):1599-1604
Simon R Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data | 0 | 0.00 | 0 | 0.00 | 0 | |
| 152 | 1 | 21 | 152 2003 BULLETIN DU CANCER 90(2):127-130
Minvielle S Gene expression profiling of multiple myeloma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 153 | 1 | 58 | 153 2003 CANCER 97(12):2960-2971
Symmans WF; Ayers M; Clark EA; Stec J; Hess KR; Sneige N; Buchholz TA; Krishnamurthy S; Ibrahim NK; Buzdar AU; Theriault RL; Rosales MFM; Thomas ES; Gwyn KM; Green MC; Syed AR; Hortobagyi GN; Pusztai L Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core needle biopsy samples of breast carcinoma | 1 | 1.00 | 2 | 2.00 | 1 | |
| 154 | 1 | 106 | 154 2003 CANCER 98(2):413-423
Nathanson SD Insights into the mechanisms of lymph node metastasis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 155 | 1 | 13 | 155 2003 CANCER 98(6):1327-1328
Kennedy RD; Quinn JE; Mullan PB; Harkin DP The biology of breast carcinoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 156 | 1 | 7 | 156 2003 CANCER 98(6):1328-1329
Keen JC; Davidson NE The biology of breast carcinoma - Author reply | 0 | 0.00 | 0 | 0.00 | 0 | |
| 157 | 4 | 23 | 157 2003 CANCER 98(8):1569-1577
Foulkes WD; Metcalfe K; Hanna W; Lynch HT; Ghadirian P; Tung N; Olopade O; Weber B; McLennan J; Olivotto IA; Sun P; Chappuis PO; Begin LR; Brunet JS; Narod SA Disruption of the expected positive correlation between breast tumor size and lymph node status in BRCA1-related breast carcinoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 158 | 2 | 10 | 158 2003 CANCER CELL 3(5):417-420
Olopade OI; Wei MJ FANCF methylation contributes to chemoselectivity in ovarian cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 159 | 3 | 50 | 159 2003 CANCER CELL 3(6):537-549
Kang YB; Siegel PM; Shu WP; Drobnjak M; Kakonen SM; Cordon-Cardo C; Guise TA; Massague J A multigenic program mediating breast cancer metastasis to bone | 2 | 2.00 | 8 | 8.00 | 2 | |
| 160 | 2 | 80 | 160 2003 CANCER CELL 4(3):209-221
Wang SY; Gao J; Lei QY; Rozengurt N; Pritchard C; Jiao J; Thomas GV; Li G; Roy-Burman P; Nelson PS; Liu X; Wu H Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 161 | 1 | 10 | 161 2003 CANCER CHEMOTHERAPY AND PHARMACOLOGY 52():S57-S60
Dracopoli NC Pharmacogenomic applications in clinical drug development | 0 | 0.00 | 0 | 0.00 | 0 | |
| 162 | 1 | 16 | 162 2003 CANCER DETECTION AND PREVENTION 27(5):405-411
Li YW; Ali S; Philip PA; Sarkar FH Direct comparison of microarray gene expression profiles between non-amplification and a modified cDNA amplification procedure applicable for needle biopsy tissues | 0 | 0.00 | 0 | 0.00 | 0 | |
| 163 | 1 | 37 | 163 2003 CANCER GENETICS AND CYTOGENETICS 143(1):89-91
Duesberg PH Are cancers dependent on oncogenes or on aneuploidy? | 0 | 0.00 | 0 | 0.00 | 0 | |
| 164 | 1 | 28 | 164 2003 CANCER GENETICS AND CYTOGENETICS 147(1):28-35
Ulger C; Toruner GA; Alkan M; Mohammed M; Damani S; Kang J; Galante A; Aviv H; Soteropoulos P; Tolias PP; Schwalb MN; Dermody JJ Comprehensive genome-wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line | 0 | 0.00 | 0 | 0.00 | 0 | |
| 165 | 3 | 101 | 165 2003 CANCER LETTERS 190(2):125-133
Nephew KP; Huang THM Epigenetic gene silencing in cancer initiation and progression | 0 | 0.00 | 5 | 5.00 | 0 | |
| 166 | 5 | 56 | 166 2003 CANCER LETTERS 200(2):97-105
Hunter KW Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination | 0 | 0.00 | 0 | 0.00 | 0 | |
| 167 | 1 | 64 | 167 2003 CANCER RESEARCH 63(1):132-139
Kumar-Sinha C; Ignatoski KW; Lippman ME; Ethier SP; Chinnaiyan AM Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis | 0 | 0.00 | 3 | 3.00 | 0 | |
| 168 | 1 | 26 | 168 2003 CANCER RESEARCH 63(2):417-423
Ramus SJ; Pharoah PDP; Harrington P; Pye C; Werness B; Bobrow L; Ayhan A; Wells D; Fishman A; Gore M; DiCioccio RA; Piver MS; Whittemore AS; Ponder BAJ; Gayther SA BRCA1/2 mutation status influences somatic genetic progression in inherited and sporadic epithelial ovarian cancer cases | 0 | 0.00 | 1 | 1.00 | 0 | |
| 169 | 1 | 37 | 169 2003 CANCER RESEARCH 63(8):1920-1926
Maula SM; Luukkaa M; Grenman R; Jackson D; Jalkanen S; Ristamaki R Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region | 0 | 0.00 | 3 | 3.00 | 0 | |
| 170 | 1 | 62 | 170 2003 CANCER RESEARCH 63(9):2200-2205
Lamendola DE; Duan ZF; Yusuf RZ; Seiden MV Molecular description of evolving paclitaxel resistance in the SKOV-3 human ovarian carcinoma cell line | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 171 | 1 | 60 | 171 2003 CANCER RESEARCH 63(10):2616-2623
Phelps M; Darley M; Primrose JN; Blaydes JP p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells | 0 | 0.00 | 0 | 0.00 | 0 | |
| 172 | 2 | 55 | 172 2003 CANCER RESEARCH 63(12):3386-3394
Xue CS; Plieth D; Venkov C; Xu C; Neilson EG The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis | 0 | 0.00 | 1 | 1.00 | 0 | |
| 173 | 2 | 25 | 173 2003 CANCER RESEARCH 63(14):4196-4203
Henshall SM; Afar DEH; Hiller J; Horvath LG; Quinn DI; Rasiah KK; Gish K; Willhite D; Kench JG; Gardiner-Garden M; Stricker PD; Scher HI; Grygiel JJ; Agus DB; Mack DH; Sutherland RL Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse | 0 | 0.00 | 1 | 1.00 | 0 | |
| 174 | 1 | 38 | 174 2003 CANCER RESEARCH 63(15):4626-4631
Feldman RJ; Sementchenko VI; Gayed M; Fraig MM; Watson DK Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression | 0 | 0.00 | 0 | 0.00 | 0 | |
| 175 | 1 | 28 | 175 2003 CANCER RESEARCH 63(16):5159-5164
Ishibashi Y; Hanyu N; Nakada K; Suzuki Y; Yamamoto T; Yanaga K; Ohkawa K; Hashimoto N; Nakajima T; Saito H; Matsushima M; Urashima M Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 176 | 1 | 31 | 176 2003 CANCER RESEARCH 63(17):5352-5356
O'Hagan RC; Brennan CW; Strahs A; Zhang XG; Kannan K; Donovan M; Cauwels C; Sharpless NE; Wong WH; Chin L Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 177 | 2 | 21 | 177 2003 CANCER RESEARCH 63(18):5679-5684
Woelfle U; Cloos J; Sauter G; Riethdorf L; Janicke F; van Diest P; Brakenhoff R; Pantel K Molecular signature associated with bone marrow micrometastasis in human breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 178 | 1 | 60 | 178 2003 CANCER RESEARCH 63(20):6772-6783
Davol PA; Bagdasaryan R; Elfenbein GJ; Maizel AL; Frackelton AR Shc proteins are strong, independent prognostic markers for both node-negative and node-positive primary breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 179 | 3 | 57 | 179 2003 CANCER RESEARCH 63(21):7158-7166
Cunliffe HE; Ringner M; Bilke S; Walker RL; Cheung JM; Chen YD; Meltzer PS The gene expression response of breast cancer to growth regulators: Patterns and correlation with tumor expression profiles | 0 | 0.00 | 0 | 0.00 | 0 | |
| 180 | 3 | 53 | 180 2003 CANCER RESEARCH 63(21):7167-7175
Korkola JE; DeVries S; Fridlyand J; Hwang ES; Estep ALH; Chen YY; Chew KL; Dairkee SH; Jensen RM; Waldman FM Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 181 | 3 | 32 | 181 2003 CANCER RESEARCH 63(22):7641-7645
Muller HM; Widschwendter A; Fiegl H; Ivarsson L; Goebel G; Perkmann E; Marth C; Widschwendter M DNA methylation in serum of breast cancer patients: An independent prognostic marker | 0 | 0.00 | 0 | 0.00 | 0 | |
| 182 | 1 | 66 | 182 2003 CELL 112(2):207-217
Yen HCS; Gordon C; Chang EC Schizosaccharomyces pombe Int6 and Ras homologs regulate cell division and mitotic fidelity via the proteasome | 0 | 0.00 | 4 | 4.00 | 0 | |
| 183 | 2 | 47 | 183 2003 CELL 113(2):207-219
Fujita N; Jaye DL; Kajita M; Geigerman C; Moreno CS; Wade PA MTA3, a Mi-2/NuRD complex subunit, an invasive growth pathway in breast | 0 | 0.00 | 7 | 7.00 | 0 | |
| 184 | 6 | 19 | 184 2003 CELL 113(7):821-823
Hynes RO Metastatic potential: Generic predisposition of the primary tumor or rare, metastatic variants - or both? | 1 | 1.00 | 2 | 2.00 | 1 | |
| 185 | 2 | 48 | 185 2003 CELL 114(3):323-334
Lamb J; Ramaswamy S; Ford HL; Contreras B; Martinez RV; Kittrell FS; Zahnow CA; Patterson N; Golub TR; Ewen ME A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer | 0 | 0.00 | 3 | 3.00 | 0 | |
| 186 | 2 | 55 | 186 2003 CELL PROLIFERATION 36():59-72
Dontu G; Al-Hajj M; Abdallah WA; Clarke MF; Wicha MS Stem cells in normal breast development and breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 187 | 3 | 23 | 187 2003 CLINICAL AND EXPERIMENTAL MEDICINE 3(1):1-3
Sevenet N; Cussenot O DNA microarrays in clinical practice: past, present, and future | 0 | 0.00 | 0 | 0.00 | 0 | |
| 188 | 1 | 80 | 188 2003 CLINICAL CANCER RESEARCH 9(3):931-946
Williams NS; Gaynor RB; Scoggin S; Verma U; Gokaslan T; Simmang C; Fleming J; Tavana D; Frenkel E; Becerra C Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference | 1 | 1.00 | 2 | 2.00 | 1 | |
| 189 | 1 | 29 | 189 2003 CLINICAL CANCER RESEARCH 9(5):1792-1800
Barden CB; Shister KW; Zhu BX; Guiter G; Greenblatt DY; Zeiger MA; Fahey TJ Classification of follicular thyroid tumors by molecular signature: Results of gene profiling | 0 | 0.00 | 1 | 1.00 | 0 | |
| 190 | 1 | 32 | 190 2003 CLINICAL CANCER RESEARCH 9(7):2406-2415
Pusztai L; Ayers M; Stec J; Clark E; Hess K; Stivers D; Damokosh A; Sneige N; Buchholz TA; Esteva FJ; Arun B; Cristofanilli M; Booser D; Rosales M; Valero V; Adams C; Hortobagyi GN; Symmans WF Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 191 | 2 | 28 | 191 2003 CLINICAL CANCER RESEARCH 9(15):5486-5492
Wong YF; Selvanayagam ZE; Wei N; Porter J; Vittal R; Hu R; Lin Y; Liao J; Shih JW; Cheung TH; Lo KWK; Yim SF; Yip SK; Ngong DT; Siu N; Chan LKY; Chan CS; Kong T; Kutlina E; McKinnon RD; Denhardt DT; Chin KV; Chung TKH Expression Genomics of cervical cancer: Molecular classification and prediction of radiotherapy response by DNA microarray | 0 | 0.00 | 0 | 0.00 | 0 | |
| 192 | 1 | 25 | 192 2003 CLINICAL CHEMISTRY 49(5):752-760
Poon TCW; Yip TT; Chan ATC; Yip C; Yip V; Mok TSK; Lee CCY; Leung TWT; Ho SKW; Johnson PJ Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes | 0 | 0.00 | 2 | 2.00 | 0 | |
| 193 | 1 | 39 | 193 2003 CLINICAL CHEMISTRY AND LABORATORY MEDICINE 41(4):462-467
Ferrari M; Stenirri S; Bonini P; Cremonesi L Molecular diagnostics by microelectronic microchips | 0 | 0.00 | 0 | 0.00 | 0 | |
| 194 | 1 | 52 | 194 2003 CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (415):S100-S104
O'Keefe RJ; Guise TA Molecular mechanisms of bone metastasis and therapeutic implications | 0 | 0.00 | 0 | 0.00 | 0 | |
| 195 | 2 | 181 | 195 2003 CURRENT MEDICINAL CHEMISTRY 10(8):691-706
Goessl C Noninvasive molecular detection of cancer - the bench and the bedside | 0 | 0.00 | 1 | 1.00 | 0 | |
| 196 | 1 | 24 | 196 2003 CURRENT OPINION IN BIOTECHNOLOGY 14(3):328-331
Winnacker EL Interdisciplinary sciences in the 21st century | 0 | 0.00 | 0 | 0.00 | 0 | |
| 197 | 4 | 37 | 197 2003 CURRENT OPINION IN CELL BIOLOGY 15(2):213-220
Ciro M; Bracken AP; Helin K Profiling cancer | 0 | 0.00 | 1 | 1.00 | 0 | |
| 198 | 1 | 46 | 198 2003 CURRENT OPINION IN CHEMICAL BIOLOGY 7(4):490-495
Fischer OM; Streit S; Hart S; Ullrich A Beyond Herceptin and Gleevec | 0 | 0.00 | 0 | 0.00 | 0 | |
| 199 | 4 | 124 | 199 2003 CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT 6(3):384-395
Xiang ZY; Yang YN; Ma XJ; Ding W Microarray expression profiling: Analysis and applications | 0 | 0.00 | 0 | 0.00 | 0 | |
| 200 | 3 | 37 | 200 2003 CURRENT OPINION IN GENETICS & DEVELOPMENT 13(1):97-103
Liu ET Classification of cancers by expression profiling | 2 | 2.00 | 2 | 2.00 | 2 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 201 | 2 | 37 | 201 2003 CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION 12(4):407-414
Hayden PS; El-Meanawy A; Schelling JR; Sedor JR DNA expression analysis: serial analysis of gene expression, microarrays and kidney disease | 0 | 0.00 | 0 | 0.00 | 0 | |
| 202 | 1 | 96 | 202 2003 CURRENT OPINION IN ONCOLOGY 15(1):36-43
Guo QM DNA microarray and cancer | 1 | 1.00 | 1 | 1.00 | 1 | |
| 203 | 1 | 30 | 203 2003 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 128(39):2030-2036
Tschoep K; Kohlmann A; Schlemmer M; Haferlach T; Issels R Gene expression analysis in sarcoma using microarray technology | 0 | 0.00 | 0 | 0.00 | 0 | |
| 204 | 1 | 30 | 204 2003 DIAGNOSTIC MOLECULAR PATHOLOGY 12(1):27-34
Callagy G; Cattaneo E; Daigo Y; Happerfield L; Bobrow LG; Pharoah PDP; Caldas C Molecular classification of breast carcinomas using tissue microarrays | 1 | 1.00 | 0 | 0.00 | 1 | |
| 205 | 2 | 41 | 205 2003 DRUG DISCOVERY TODAY 8(8):356-363
Huang Y; Sadee W Drug sensitivity and resistance genes in cancer chemotherapy: a chemogenomics approach | 0 | 0.00 | 1 | 1.00 | 0 | |
| 206 | 1 | 68 | 206 2003 DRUG DISCOVERY TODAY 8(8):364-371
Zhang WW The use of gene-specific IgY antibodies for drug target discovery | 0 | 0.00 | 1 | 1.00 | 0 | |
| 207 | 3 | 22 | 207 2003 DRUG NEWS & PERSPECTIVES 16(4):217-221
Gant TW Application of toxicogenomics in drug development | 0 | 0.00 | 0 | 0.00 | 0 | |
| 208 | 2 | 153 | 208 2003 ENDOCRINE-RELATED CANCER 10(2):225-259
Simard J; Dumont M; Labuda D; Sinnett D; Meloche C; El-Alfy M; Berger L; Lees E; Labrie F; Tavtigian SV Prostate cancer susceptibility genes: lessons learned and challenges posed | 0 | 0.00 | 0 | 0.00 | 0 | |
| 209 | 3 | 58 | 209 2003 ENDOCRINOLOGY 144(10):4562-4574
Frasor J; Danes JM; Komm B; Chang KCN; Lyttle CR; Katzenellenbogen BS Profiling of estrogen up-and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype | 0 | 0.00 | 0 | 0.00 | 0 | |
| 210 | 1 | 38 | 210 2003 ENDOCRINOLOGY 144(12):5650-5657
Lin VCL; Woon CT; Aw SE; Guo CH Distinct molecular pathways mediate progesterone-induced growth inhibition and focal adhesion | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 211 | 1 | 49 | 211 2003 EUROPEAN JOURNAL OF CANCER 39(7):932-944
Vrieling C; Collette L; Fourquet A; Hoogenraad WJ; Horiot JC; Jager JJ; Oei SB; Peterse HL; Pierart M; Poortmans PM; Struikmans H; Van den Bogaert W; Bartelink H; EORTC Can patient-, treatment-and pathology-related characteristics explain the high local recurrence rate following breast-conserving therapy in young patients? | 0 | 0.00 | 0 | 0.00 | 0 | |
| 212 | 1 | 101 | 212 2003 EUROPEAN JOURNAL OF CONTROL 9(2-3):237-278
De Moor B; Marchal K; Mathys J; Moreau Y Bioinformatics: Organisms from Venus, technology from Jupiter, algorithms from Mars | 0 | 0.00 | 0 | 0.00 | 0 | |
| 213 | 1 | 142 | 213 2003 EXPERIMENTAL CELL RESEARCH 284(1):99-110
Holbro T; Civenni G; Hynes NE The ErbB receptors and their role in cancer progression | 0 | 0.00 | 5 | 5.00 | 0 | |
| 214 | 1 | 11 | 214 2003 FEBS LETTERS 533(1-3):110-114
Korenberg MJ Gene expression monitoring accurately predicts medulloblastoma positive and negative clinical outcomes | 0 | 0.00 | 0 | 0.00 | 0 | |
| 215 | 1 | 14 | 215 2003 FEBS LETTERS 538(1-3):117-124
Xiao L; Wang KK; Teng Y; Zhang J Component plane presentation integrated self-organizing map for microarray data analysis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 216 | 7 | 46 | 216 2003 FEBS LETTERS 546(1):98-102
Detours V; Dumont JE; Bersini H; Maenhaut C Integration and cross-validation of high-throughput gene expression data: comparing heterogeneous data sets | 0 | 0.00 | 0 | 0.00 | 0 | |
| 217 | 1 | 47 | 217 2003 GENES AND IMMUNITY 4(5):336-342
Dhillon NK; Mudryj M Cyclin E overexpression enhances cytokine-mediated apoptosis in MCF7 breast cancer cells | 0 | 0.00 | 0 | 0.00 | 0 | |
| 218 | 2 | 37 | 218 2003 GENES CHROMOSOMES & CANCER 38(3):207-214
Lu YJ; Williamson D; Wang R; Summersgill B; Rodriguez S; Rogers S; Pritchard-Jones K; Campbell C; Shipley J Expression profiling targeting chromosomes for tumor classification and prediction of clinical behavior | 0 | 0.00 | 0 | 0.00 | 0 | |
| 219 | 1 | 81 | 219 2003 GENETIC EPIDEMIOLOGY 24(2):83-98
Sellers TA; Yates JR Review of proteomics with applications to genetic epidemiology | 0 | 0.00 | 3 | 3.00 | 0 | |
| 220 | 1 | 32 | 220 2003 GENOME BIOLOGY 4(3):art. no.-R21
Muro S; Takemasa I; Oba S; Matoba R; Ueno N; Maruyama C; Yamashita R; Sekimoto M; Yamamoto H; Nakamori S; Monden M; Ishii S; Kato K Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data | 0 | 0.00 | 2 | 2.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 221 | 1 | 35 | 221 2003 GENOME BIOLOGY 4(5):art. no.-R34
Yeung KY; Medvedovic M; Bumgarner RE Clustering gene-expression data with repeated measurements | 0 | 0.00 | 1 | 1.00 | 0 | |
| 222 | 1 | 34 | 222 2003 GENOME BIOLOGY 4(12):art. no.-R83
Yeung KY; Bumgarner RE Multiclass classification of microarray data with repeated measurements: application to cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 223 | 1 | 39 | 223 2003 GENOME RESEARCH 13(5):1011-1021
Carter MG; Hamatani T; Sharov AA; Carmack CE; Qian Y; Aiba K; Ko NT; Dudekula DB; Brzoska PM; Hwang SS; Ko MSH In situ-synthesized novel microarray optimized for mouse stem cell and early developmental expression profiling | 0 | 0.00 | 0 | 0.00 | 0 | |
| 224 | 1 | 32 | 224 2003 GENOME RESEARCH 13(7):1719-1727
Akilesh S; Shaffer DJ; Roopenian D Customized molecular phenotyping by quantitative gene expression and pattern recognition analysis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 225 | 1 | 26 | 225 2003 GENOME RESEARCH 13(10):2291-2305
Lucito R; Healy J; Alexander J; Reiner A; Esposito D; Chi MY; Rodgers L; Brady A; Sebat J; Troge J; West JA; Rostan S; Nguyen KCQ; Powers S; Ye KQ; Olshen A; Venkatraman E; Norton L; Wigler M Representational oligonucleotide microarray analysis: A high-resolution method to detect genome copy number variation | 0 | 0.00 | 0 | 0.00 | 0 | |
| 226 | 1 | 34 | 226 2003 GENOMICS 81(2):98-104
Draghici S; Khatri P; Martins RP; Ostermeier GC; Krawetz SA Global functional profiling of gene expression | 2 | 2.00 | 4 | 4.00 | 2 | |
| 227 | 1 | 27 | 227 2003 GUT 52():II1-II5
Thomas G; Cann H Irruption of genomics in the search for disease related genes | 0 | 0.00 | 0 | 0.00 | 0 | |
| 228 | 1 | 2 | 228 2003 GYNAKOLOGE 36(11):1011-1013
Costa SD Gene expression pattern as prognostic factor in breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 229 | 1 | 35 | 229 2003 GYNECOLOGIC ONCOLOGY 88(1):S4-S7
Strong LC General keynote: Hereditary cancer: Lessons from Li-Fraumeni syndrome | 0 | 0.00 | 0 | 0.00 | 0 | |
| 230 | 1 | 46 | 230 2003 HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 17(2):377-+
Mariadason JM; Augenlicht LH; Arango D Microarray analysis in the clinical management of cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 231 | 1 | 43 | 231 2003 HEPATOLOGY 37(1):198-207
Chuma M; Sakamoto M; Yamazaki K; Ohta T; Ohki M; Asaka M; Hirohashi S Expression profiling in multistage hepatocarcinogenesis: Identification of HSP70 as a molecular marker of early hepatocellular carcinoma | 0 | 0.00 | 6 | 6.00 | 0 | |
| 232 | 1 | 41 | 232 2003 HISTOPATHOLOGY 43(2):118-126
Wong NACS; Young R; Malcomson RDG; Nayar AG; Jamieson LA; Save VE; Carey FA; Brewster DH; Han C; Al-Nafussi A Prognostic indicators for gastrointestinal stromal tumours: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach | 0 | 0.00 | 0 | 0.00 | 0 | |
| 233 | 1 | 29 | 233 2003 HUMAN GENETICS 112(5-6):581-592
Perez-Enciso M; Tenenhaus M Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach | 0 | 0.00 | 1 | 1.00 | 0 | |
| 234 | 3 | 12 | 234 2003 HUMAN MOLECULAR GENETICS 12():R153-R157
Nevins JR; Huang ES; Dressman H; Pittman J; Huang AT; West M Towards integrated clinico-genomic models for personalized medicine: combining gene expression signatures and clinical factors in breast cancer outcomes prediction | 0 | 0.00 | 0 | 0.00 | 0 | |
| 235 | 1 | 28 | 235 2003 HUMAN MOLECULAR GENETICS 12(24):3245-3258
Kun Y; How LC; Hoon TP; Bajic VB; Lam TS; Aggarwal A; Sze HG; Bok WS; Yin WC; Tan P Classifying the estrogen receptor status of breast cancers by expression profiles reveals a poor prognosis subpopulation exhibiting high expression of the ERBB2 receptor | 0 | 0.00 | 0 | 0.00 | 0 | |
| 236 | 1 | 54 | 236 2003 IMMUNOLOGY AND CELL BIOLOGY 81(1):79-85
Mckenzie IF; Apostolopoulos V; Plebanski M; Pietersz GA; Loveland BE Aspects of cancer immunotherapy | 0 | 0.00 | 1 | 1.00 | 0 | |
| 237 | 2 | 15 | 237 2003 INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY 35(2):119-124
Schmidt U; Begley CG Cancer diagnosis and microarrays | 0 | 0.00 | 0 | 0.00 | 0 | |
| 238 | 1 | 16 | 238 2003 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 18(1):36-39
Biglia N; De Bortoli M Molecular characterization of breast cancer aggressiveness | 0 | 0.00 | 0 | 0.00 | 0 | |
| 239 | 1 | 7 | 239 2003 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 18(1):54-56
Borresen-Dale AL Genetic profiling of breast cancer: From molecular portraits to clinical utility | 0 | 0.00 | 0 | 0.00 | 0 | |
| 240 | 2 | 25 | 240 2003 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 18(2):123-129
Sorbello V; Fuso L; Sfiligoi C; Scafoglio C; Ponzone R; Biglia N; Weisz A; Sismondi P; De Bortoli M Quantitative real-time RT-PCR analysis of eight novel estrogen-regulated genes in breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 241 | 1 | 56 | 241 2003 INTERNATIONAL JOURNAL OF CANCER 105(1):53-60
Kalembeyi I; Inada H; Nishiura R; Imanaka-Yoshida K; Sakakura T; Yoshida T Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: Direct and synergistic effects with transforming growth factor beta 1 | 0 | 0.00 | 0 | 0.00 | 0 | |
| 242 | 1 | 53 | 242 2003 INTERNATIONAL JOURNAL OF CANCER 105(4):533-541
Kitamura N; Guo SC; Sato T; Hiraizumi S; Taka J; Ikeita M; Sawada S; Fujisawa H; Furukawa K Prognostic significance of reduced expression of beta-N-acetylgalactosaminylated N-linked oligosaccharides in human breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 243 | 1 | 17 | 243 2003 INTERNATIONAL JOURNAL OF CANCER 106(1):74-77
Rhiem K; Klein A; Munch M; Kreutzfeld R; Ramser J; Wardelmann E; Schackert G; von Deimling A; Wiestler OD; Schmutzler RK Chromosomal region 15q21.1 is a frequent target of allelic imbalance in advanced breast carcinomas | 0 | 0.00 | 0 | 0.00 | 0 | |
| 244 | 3 | 46 | 244 2003 INTERNATIONAL JOURNAL OF CANCER 107(5):854-862
Ginestier C; Bardou VJ; Popovici C; Charafe-Jauffret E; Bertucci F; Geneix J; Adelaide J; Chaffanet M; Hassoun J; Viens P; Jacquemier J; Birnbaum D Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 245 | 1 | 38 | 245 2003 INTERNATIONAL JOURNAL OF ONCOLOGY 23(4):965-973
Ohshima K; Hamasaki M; Makimoto Y; Yoneda S; Fujii A; Takamatsu Y; Nakashima M; Watanabe T; Kawahara K; Kikuchi M; Shirakusa T Differential chemokine, chemokine receptor, cytokine and cytokine receptor expression in pulmonary adenocarcinoma: Diffuse down-regulation is associated with immune evasion and brain metastasis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 246 | 1 | 43 | 246 2003 INTERNATIONAL JOURNAL OF ONCOLOGY 23(5):1425-1430
Nagai MA; Ros N; Bessa SA; Neto MM; Miracca EC; Brentani MM Differentially expressed genes and estrogen receptor status in breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 247 | 2 | 77 | 247 2003 JOURNAL OF ANDROLOGY 24(6):783-789
Moldenhauer JS; Ostermeier GC; Johnson A; Diamond MP; Krawetz SA Diagnosing male factor infertility using microarrays | 0 | 0.00 | 0 | 0.00 | 0 | |
| 248 | 1 | 54 | 248 2003 JOURNAL OF BIOLOGICAL RHYTHMS 18(2):96-105
Sato TK; Panda S; Kay SA; Hogenesch JB DNA arrays: Applications and implications for circadian biology | 0 | 0.00 | 1 | 1.00 | 0 | |
| 249 | 2 | 58 | 249 2003 JOURNAL OF CELLULAR BIOCHEMISTRY 89(1):120-132
McEachern KA; Archey WB; Douville K; Arrick BA BRCA1 splice variants exhibit overlapping and distinct transcriptional transactivation activities | 0 | 0.00 | 1 | 1.00 | 0 | |
| 250 | 1 | 296 | 250 2003 JOURNAL OF CELLULAR PHYSIOLOGY 196(1):19-41
Rosen EM; Fan SJ; Pestell RG; Goldberg ID BRCA1 gene in breast cancer | 0 | 0.00 | 4 | 4.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 251 | 1 | 84 | 251 2003 JOURNAL OF CLINICAL ONCOLOGY 21(4):740-753
Lynch HT; Snyder CL; Lynch JF; Riley BD; Rubinstein WS Hereditary breast-ovarian cancer at the bedside: Role of the medical oncologist | 0 | 0.00 | 2 | 2.00 | 0 | |
| 252 | 1 | 7 | 252 2003 JOURNAL OF CLINICAL ONCOLOGY 21(16):3180-3180
Menard S; Biganzoli E; Valagussa P; Boracchi P; Moliterni A The predictive role of HER2 overexpression in early breast cancer - Reply | 0 | 0.00 | 0 | 0.00 | 0 | |
| 253 | 1 | 28 | 253 2003 JOURNAL OF CLINICAL ONCOLOGY 21(18):3469-3478
Wiedswang G; Borgen E; Karesen R; Kvalheim G; Nesland JM; Schlichting HQE; Sauer T; Janbu J; Harbitz T; Naume B Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 254 | 3 | 29 | 254 2003 JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY 56(4):198-204
Packeisen J; Korsching E; Herbst H; Boecker W; Buerger H Demystified ... Tissue microarray technology | 0 | 0.00 | 0 | 0.00 | 0 | |
| 255 | 1 | 21 | 255 2003 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 86(3-5):301-307
Ellis MJ; Rosen E; Dressman H; Marks J Neoadjuvant comparisons of aromatase inhibitors and tamoxifen: pretreatment determinants of response and on-treatment effect | 0 | 0.00 | 0 | 0.00 | 0 | |
| 256 | 1 | 43 | 256 2003 JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY 86(3-5):433-442
Hayashi S; Sakamoto T; Inoue A; Yoshida N; Omoto Y; Yamaguchi Y Estrogen and growth factor signaling pathway: basic approaches for clinical application | 0 | 0.00 | 0 | 0.00 | 0 | |
| 257 | 2 | 22 | 257 2003 JOURNAL OF THE NATIONAL CANCER INSTITUTE 95(1):14-18
Simon R; Radmacher MD; Dobbin K; McShane LM Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification | 4 | 4.00 | 15 | 15.00 | 4 | |
| 258 | 1 | 25 | 258 2003 JOURNAL OF THE NATIONAL CANCER INSTITUTE 95(8):598-605
Gordon GJ; Jensen RV; Hsiao LL; Gullans SR; Blumenstock JE; Richards WG; Jaklitsch MT; Sugarbaker DJ; Bueno R Using gene expression ratios to predict outcome among patients with mesothelioma | 0 | 0.00 | 1 | 1.00 | 0 | |
| 259 | 3 | 32 | 259 2003 JOURNAL OF THE NATIONAL CANCER INSTITUTE 95(19):1482-1485
Foulkes WD; Stefansson IM; Chappuis PO; Begin LR; Goffin JR; Wong N; Trudel M; Akslen LA Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 260 | 5 | 69 | 260 2003 LABORATORY INVESTIGATION 83(3):305-316
Bertucci F; Viens P; Tagett R; Nguyen C; Houlgatte R; Birnbaum D DNA arrays in clinical oncology: Promises and challenges | 0 | 0.00 | 1 | 1.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 261 | 4 | 14 | 261 2003 LANCET 361(9369):1576-1577
Ramaswamy S; Perou CM DNA microarrays in breast cancer: the promise of personalised medicine | 0 | 0.00 | 3 | 3.00 | 0 | |
| 262 | 1 | 17 | 262 2003 LANCET 361(9369):1590-1596
Huang E; Cheng SH; Dressman H; Pittman J; Tsou MH; Horng CF; Bild A; Iversen ES; Liao M; Chen CM; West M; Nevins JR; Huang AT Gene expression predictors of breast cancer outcomes | 1 | 1.00 | 4 | 4.00 | 1 | |
| 263 | 1 | 10 | 263 2003 LANCET 362(9380):260-262
Dowsett M; Ashworth A New biology of the oestrogen receptor | 0 | 0.00 | 0 | 0.00 | 0 | |
| 264 | 3 | 33 | 264 2003 LANCET 362(9381):362-369
Chang JC; Wooten EC; Tsimelzon A; Hilsenbeck SG; Gutierrez MC; Elledge R; Mohsin S; Osborne CK; Chamness GC; Allred DC; O'Connell P Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 265 | 1 | 85 | 265 2003 LANCET ONCOLOGY 4(3):177-185
Lonning PE Study of suboptimum treatment response: lessons from breast cancer | 0 | 0.00 | 2 | 2.00 | 0 | |
| 266 | 1 | 388 | 266 2003 LEUKEMIA RESEARCH 27(2):95-120
Steensma DP; Tefferi A The myelodysplastic syndrome(s): a perspective and review highlighting current controversies | 0 | 0.00 | 1 | 1.00 | 0 | |
| 267 | 2 | 30 | 267 2003 LIFE SCIENCES 73(25):3189-3199
Zhang DH; Salto-Tellez M; Chiu LL; Shen L; Koay ESC Tissue microarray study for classification of breast tumors | 0 | 0.00 | 0 | 0.00 | 0 | |
| 268 | 2 | 32 | 268 2003 LUNG CANCER 41():S3-S8
Johnson DH Targeted therapy in non-small cell lung cancer: myth or reality | 0 | 0.00 | 0 | 0.00 | 0 | |
| 269 | 1 | 84 | 269 2003 MAYO CLINIC PROCEEDINGS 78(3):307-317
Ansell SM; Ackerman MJ; Black JL; Roberts LR; Tefferi A Primer on medical Genomics part VI: Genomics and molecular genetics in clinical practice | 0 | 0.00 | 0 | 0.00 | 0 | |
| 270 | 1 | 13 | 270 2003 MEDICAL JOURNAL OF AUSTRALIA 178(9):458-462
Haan EA The clinical geneticist and the "new genetics" | 0 | 0.00 | 1 | 1.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 271 | 2 | 29 | 271 2003 MEDICINA CLINICA 120(11):414-416
Vera-Roman JM; Rubio LA Sentinel lymph node versus functional genomics for prognosis and treatment of breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 272 | 1 | 42 | 272 2003 METHODS OF INFORMATION IN MEDICINE 42(2):126-133
Wiemer J; Schubert F; Granzow M; Ragg T; Fieres J; Mattes J; Eils R Informatics united - Exemplary studies combining medical informatics, neuroinformatics, and bioinformatics | 0 | 0.00 | 0 | 0.00 | 0 | |
| 273 | 1 | 44 | 273 2003 MOLECULAR & CELLULAR PROTEOMICS 2(7):443-452
Melle C; Ernst G; Schimmel B; Bleul A; Koscielny S; Wiesner A; Bogumi R; Moller U; Osterloh D; Halbhuber KJ; von Eggeling F Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip (R) technology, two-dimensional gel electrophoresis, tandem mass spectrometry, and immunohistochemistry | 0 | 0.00 | 0 | 0.00 | 0 | |
| 274 | 1 | 39 | 274 2003 MOLECULAR BIOLOGY OF THE CELL 14(8):3208-3215
Chen X; Leung SY; Yuen ST; Chu KM; Ji JF; Li R; Chan ASY; Law S; Troyanskaya OG; Wong J; So S; Botstein D; Brown PO Variation in gene expression patterns in human gastric cancers | 0 | 0.00 | 0 | 0.00 | 0 | |
| 275 | 1 | 64 | 275 2003 MOLECULAR BIOLOGY OF THE CELL 14(11):4376-4386
Schaner ME; Ross DT; Ciaravino G; Sorlie T; Troyanskaya O; Diehn M; Wang YC; Duran GE; Sikic TL; Caldeira S; Skomedal H; Tu IP; Hernandez-Boussard T; Johnson SW; O'Dwyer PJ; Fero MJ; Kristensen GB; Borresen-Dale AL; Hastie T; Tibshirani R; van de Rijn M; Teng NN; Longacre TA; Botstein D; Brown PO; Sikic BI Gene expression patterns in ovarian carcinomas | 0 | 0.00 | 0 | 0.00 | 0 | |
| 276 | 2 | 25 | 276 2003 MOLECULAR CANCER RESEARCH 1(11):826-835
Adam PJ; Berry J; Loader JA; Tyson KL; Craggs G; Smith P; De Belin J; Steers G; Pezzella F; Sachsenmeir KF; Stamps AC; Herath A; Sim E; O'Hare MJ; Harris AL; Terrett JA Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistance to etoposide in vitro | 0 | 0.00 | 0 | 0.00 | 0 | |
| 277 | 1 | 55 | 277 2003 MOLECULAR CANCER THERAPEUTICS 2(8):773-782
Fan YP; Borowsky AD; Weiss RH An antisense oligodeoxynucleotide to p21 (Waf1/Cip1) causes apoptosis in human breast cancer cells | 0 | 0.00 | 1 | 1.00 | 0 | |
| 278 | 1 | 25 | 278 2003 NATURE 422(6929):297-302
Schadt EE; Monks SA; Drake TA; Lusis AJ; Che N; Colinayo V; Ruff TG; Milligan SB; Lamb JR; Cavet G; Linsley PS; Mao M; Stoughton RB; Friend SH Genetics of gene expression surveyed in maize, mouse and man | 1 | 1.00 | 19 | 19.00 | 1 | |
| 279 | 1 | 198 | 279 2003 NATURE GENETICS 33():311-323
Patterson SD; Aebersold RH Proteomics: the first decade and beyond | 0 | 0.00 | 11 | 11.00 | 0 | |
| 280 | 3 | 29 | 280 2003 NATURE GENETICS 33(1):49-54
Ramaswamy S; Ross KN; Lander ES; Golub TR A molecular signature of metastasis in primary solid tumors | 15 | 15.00 | 43 | 43.00 | 15 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 281 | 1 | 26 | 281 2003 NATURE GENETICS 33(1):90-96
Dyrskjot L; Thykjaer T; Kruhoffer M; Jensen JL; Marcussen N; Hamilton-Dutoit S; Wolf H; Orntoft TF Identifying distinct classes of bladder carcinoma using microarrays | 2 | 2.00 | 12 | 12.00 | 2 | |
| 282 | 3 | 9 | 282 2003 NATURE GENETICS 34(1):23-24
Hunter K; Welch DR; Liu ET Genetic background is an important determinant of metastatic potential | 1 | 1.00 | 1 | 1.00 | 1 | |
| 283 | 1 | 14 | 283 2003 NATURE GENETICS 34(2):226-230
Huang E; Ishida S; Pittman J; Dressman H; Bild A; Kloos M; D'Amico M; Pestell RG; West M; Nevins JR Gene expression phenotypic models that predict the activity of oncogenic pathways | 0 | 0.00 | 4 | 4.00 | 0 | |
| 284 | 4 | 162 | 284 2003 NATURE GENETICS 34(4):369-376
Albertson DG; Collins C; McCormick F; Gray JW Chromosome aberrations in solid tumors | 0 | 0.00 | 1 | 1.00 | 0 | |
| 285 | 2 | 14 | 285 2003 NATURE MEDICINE 9(1):16-18
Borg A; Ferno M; Peterson C Predicting the future of breast cancer | 0 | 0.00 | 1 | 1.00 | 0 | |
| 286 | 5 | 10 | 286 2003 NATURE MEDICINE 9(8):999-1000
Van't Veer LJ; Weigelt B Road map to metastasis | 0 | 0.00 | 0 | 0.00 | 0 | |
| 287 | 2 | 2 | 287 2003 NATURE REVIEWS CANCER 3(2):82-83
Hutchinson E Prediction power | 0 | 0.00 | 0 | 0.00 | 0 | |
| 288 | 2 | 168 | 288 2003 NATURE REVIEWS CANCER 3(7):502-516
Agarwal R; Kaye SB Ovarian cancer: Strategies for overcoming resistance to chemotherapy | 0 | 0.00 | 1 | 1.00 | 0 | |
| 289 | 2 | 78 | 289 2003 NATURE REVIEWS CANCER 3(12):912-920
Ulrich CM; Robien K; McLeod HL Cancer pharmacogenetics: Polymorphisms, pathways and beyond | 0 | 0.00 | 0 | 0.00 | 0 | |
| 290 | 2 | 150 | 290 2003 NATURE REVIEWS DRUG DISCOVERY 2(4):296-313
Dancey J; Sausville EA Issues and progress with protein kinase inhibitors for cancer treatment | 0 | 0.00 | 13 | 13.00 | 0 | |
| # | LCR | NCR | Nodes / Authors / Date | LCS | LCS/t | GCS | GCS/t | LCSb | LCSe |
| 291 | 1 | 37 | 291 2003 NATURE REVIEWS MOLECULAR CELL BIOLOGY 4(1):74-80
Huber LA Is proteomics heading in the wrong direction? | 0 | 0.00 | 6 | 6.00 | 0 | |
| 292 | 1 | 1 | 292 2003 NEW ENGLAND JOURNAL OF MEDICINE 348(17):1716-1716
Ransohoff DF Gene-expression signatures in breast cancer | 0 | 0.00 | 0 | 0.00 | 0 | |
| 293 | 1 | 17 | 293 2003 NEW TRENDS IN CANCER FOR THE 21ST CENTURY 532():19-26
Hofler H; Specht K; Becker KF Molecular analysis of gene expression in tumor pathology | 0 | 0.00 | 0 | 0.00 | 0 | |
| 294 | 1 | 18 | 294 2003 NEW TRENDS IN CANCER FOR THE 21ST CENTURY 532():223-234
Ellis MJ Breast cancer gene expression analysis - The case for dynamic profiling | 0 | 0.00 | 0 | 0.00 | 0 | |
| 295 | 2 | 10 | 295 2003 NUCLEIC ACIDS RESEARCH 31(13):3775-3781
Draghici S; Khatri P; Bhavsar P; Shah A; Krawetz SA; Tainsky MA Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate | 0 | 0.00 | 0 | 0.00 | 0 | |
| 296 | 1 | 50 | 296 2003 NUCLEIC ACIDS RESEARCH 31(18):5266-5274
Ding LH; Yan JH; Zhu JH; Zhong HJ; Lu QJ; Wang ZH; Huang CF; Ye QN Ligand-independent activation of estrogen receptor alpha by XBP-1 | 0 | 0.00 | 0 | 0.00 | 0 | |
| 297 | 1 | 33 | 297 2003 ONCOGENE 22(14):2192-2205
Kikuchi T; Daigo Y; Katagiri T; Tsunoda T; Okada K; Kakiuchi S; Zembutsu H; Furukawa Y; Kawamura M; Kobayashi K; Imai K; Nakamura Y Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs | 0 | 0.00 | 3 | 3.00 | 0 | |
| 298 | 1 | 30 | 298 2003 ONCOGENE 22(20):3076-3080
Carr KM; Bittner M; Trent JM Gene-expression profiling in human cutaneous melanoma | 0 | 0.00 | 0 | 0.00 | 0 | |
| 299 | 1 | 40 | 299 2003 ONCOGENE 22(22):3475-3488
Levine JJ; Stimson-Crider KM; Vertino PM Effects of methylation on expression of TMS1/ASC in human breast cancer cells | 0 | 0.00 | 1 | 1.00 | 0 | |
| 300 | 1 | 73 | 300 2003 ONCOGENE 22(25):3952-3963
Nowicki MO; Pawlowski P; Fischer T; Hess G; Pawlowski T; Skorski T Chronic myelogenous leukemia molecular signature | 0 | 0.00 | 0 | 0.00 | 0 |
Page 1: 1 2
Generated by: HistCite(Vlad).
Version: 2004.01.07